Bleeding from Gynecologic Malignancies

Obstet Gynecol Clin North Am. 2022 Sep;49(3):607-622. doi: 10.1016/j.ogc.2022.02.022.

Abstract

Initial assessment of vaginal bleeding in gynecologic malignancies includes a thorough history and physical examination, identification of site and extent of disease, and patient goals of care. Patients who are initially hemodynamically unstable may require critical care services. Choice of treatment is disease site specific. Cervical cancer frequently is treated with chemoradiation. Uterine cancer may be treated surgically, with radiation, or pharmacologically. Gestational trophoblastic disease is treated surgically. Alternative treatment modalities include vascular embolization and topical hemostatic agents. Patients with bleeding gynecologic malignancies should be managed as inpatients in facilities with gynecologic oncology, radiation oncology, and critical care services.

Keywords: Gynecologic malignancy; Gynecologic oncology emergencies; Vaginal bleeding; Vaginal hemorrhage.

Publication types

  • Review

MeSH terms

  • Embolization, Therapeutic*
  • Female
  • Genital Neoplasms, Female* / complications
  • Genital Neoplasms, Female* / diagnosis
  • Genital Neoplasms, Female* / therapy
  • Hemostatics*
  • Humans
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / therapy
  • Uterine Hemorrhage / diagnosis
  • Uterine Hemorrhage / etiology
  • Uterine Hemorrhage / therapy

Substances

  • Hemostatics